• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾细胞癌根治性肾切除术后切缘状态对生存的影响。

Impact of margin status on survival after radical nephrectomy for renal cell carcinoma.

机构信息

College of Medicine (Medical School), University of Tennessee Health Science Center, Memphis, Tennessee, USA.

Department of Hematology and Oncology, University of Tennessee Health Science Center, Memphis, Tennessee, USA.

出版信息

J Surg Oncol. 2021 Feb;123(2):687-692. doi: 10.1002/jso.26321. Epub 2020 Dec 17.

DOI:10.1002/jso.26321
PMID:33333591
Abstract

BACKGROUND

Data about the impact of surgical margin positivity on patient outcomes following radical nephrectomy (RN) for renal cell carcinoma (RCC) is limited. We evaluate the effect of positive surgical margins (PSMs) on relapse-free survival (RFS) and overall survival (OS.) METHODS: Clinicopathologic data of patients who underwent RN for RCC was analyzed based on margin status. χ and Student t test were used to compare groups. Cox regression analysis was used for the analysis. Kaplan-Meier method was used for survival curves.

RESULTS

A total of 485 patients who underwent RN for RCC were analyzed. Most patients with T1/T2 stage had NSM. Most patients with T4 had PSM. T3 patients were split between the two groups. Analysis of the T3 group showed shorter RFS in the PSM group at 3 years (hazard ratio [HR]: 4.3, p = .01), and 5 years (HR: 4.3, p = .01.) OS analysis showed worse OS in PSM but not statistically significant. There was a significant association between PSM and laterality (p = .023) and histologic type (p = .025.) CONCLUSIONS: PSM was associated with shorter RFS after RN in T3 RCC patients. There was a trend towards worse OS in the PSM group, but it did not reach statistical significance. Laterality and histologic type were associated with surgical margin status.

摘要

背景

关于外科切缘阳性对肾细胞癌(RCC)根治性肾切除术(RN)后患者结局影响的数据有限。我们评估了阳性切缘(PSM)对无复发生存(RFS)和总生存(OS)的影响。

方法

根据切缘状态分析了接受 RN 治疗 RCC 的患者的临床病理数据。χ 和学生 t 检验用于比较组。Cox 回归分析用于分析。Kaplan-Meier 法用于生存曲线。

结果

共分析了 485 例接受 RN 治疗 RCC 的患者。大多数 T1/T2 期患者有 NSM。大多数 T4 期患者有 PSM。T3 患者分为两组。T3 组分析显示 PSM 组 RFS 较短,3 年(风险比 [HR]:4.3,p = 0.01)和 5 年(HR:4.3,p = 0.01)。OS 分析显示 PSM 组 OS 较差,但无统计学意义。PSM 与肿瘤侧别(p = 0.023)和组织学类型(p = 0.025)显著相关。

结论

PSM 与 T3 期 RCC 患者 RN 后 RFS 缩短有关。PSM 组 OS 较差,但无统计学意义。肿瘤侧别和组织学类型与手术切缘状态有关。

相似文献

1
Impact of margin status on survival after radical nephrectomy for renal cell carcinoma.肾细胞癌根治性肾切除术后切缘状态对生存的影响。
J Surg Oncol. 2021 Feb;123(2):687-692. doi: 10.1002/jso.26321. Epub 2020 Dec 17.
2
Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.根治性肾切除术后的阳性切缘是局部复发和疾病特异性生存的独立预测因子。
World J Surg Oncol. 2017 Nov 2;15(1):193. doi: 10.1186/s12957-017-1257-6.
3
Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.部分肾切除术切缘阳性患者的肿瘤学结果:25 年单机构经验。
World J Urol. 2018 Jul;36(7):1093-1101. doi: 10.1007/s00345-018-2241-7. Epub 2018 Feb 27.
4
Relevance of Positive Surgical Margins in Localized Renal Cell Carcinoma After Surgical Resection: Predictive Factors and Survival Implications.手术切除后局限性肾细胞癌中阳性手术切缘的相关性:预测因素和生存意义。
Clin Genitourin Cancer. 2024 Aug;22(4):102110. doi: 10.1016/j.clgc.2024.102110. Epub 2024 May 1.
5
Impact of positive surgical margins on survival after partial nephrectomy in localized kidney cancer: analysis of the National Cancer Database.局部肾细胞癌肾部分切除术后切缘阳性对生存的影响:国家癌症数据库分析。
Minerva Urol Nephrol. 2021 Apr;73(2):233-244. doi: 10.23736/S2724-6051.20.03728-5. Epub 2020 Aug 4.
6
Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years.保肾手术后切缘阳性预测肾细胞癌无复发生存:单中心 459 例病例队列的 5 年以上随访结果。
Clin Genitourin Cancer. 2019 Feb;17(1):e26-e31. doi: 10.1016/j.clgc.2018.08.004. Epub 2018 Aug 23.
7
Impact of positive surgical margins on overall survival after partial nephrectomy-A matched comparison based on the National Cancer Database.阳性手术切缘对部分肾切除术后总生存的影响——基于国家癌症数据库的匹配比较
Urol Oncol. 2018 Mar;36(3):90.e15-90.e21. doi: 10.1016/j.urolonc.2017.11.009. Epub 2017 Dec 7.
8
The effect of surgical margin on cancer-specific survival in patients treated with nephron-sparing surgery.保留肾单位手术治疗患者的手术切缘对癌症特异性生存的影响。
Niger J Clin Pract. 2019 Oct;22(10):1396-1402. doi: 10.4103/njcp.njcp_267_18.
9
Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.cT1-2/N0/M0期透明细胞肾细胞癌行微创部分肾切除术与微创根治性肾切除术的肿瘤学结局:一项倾向评分匹配分析
World J Urol. 2017 May;35(5):789-794. doi: 10.1007/s00345-016-1923-2. Epub 2016 Aug 30.
10
Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.部分和根治性肾切除术治疗良性肾肿瘤患者的 IV 期慢性肾脏病的总生存和发展。
Eur Urol. 2013 Oct;64(4):600-6. doi: 10.1016/j.eururo.2012.12.023. Epub 2012 Dec 25.

引用本文的文献

1
Positive Surgical Margins in Clear Cell Renal Cell Carcinoma: Prognostic Impact and Implications for Risk Stratification and Adjuvant Therapy.透明细胞肾细胞癌手术切缘阳性:对预后的影响及对风险分层和辅助治疗的意义
J Clin Med. 2025 Jun 2;14(11):3908. doi: 10.3390/jcm14113908.
2
Partial and Radical Nephrectomy Provides Equivalent Oncologic Outcomes in pT3a Renal Cell Carcinoma: A Population-Based Study.部分肾切除术和根治性肾切除术治疗pT3a期肾细胞癌的肿瘤学结局相当:一项基于人群的研究
Front Oncol. 2022 Jan 26;11:819098. doi: 10.3389/fonc.2021.819098. eCollection 2021.
3
Development and Validation of a Predictive Model to Evaluate the Risk of Bone Metastasis in Kidney Cancer.
评估肾癌骨转移风险预测模型的开发与验证
Front Oncol. 2021 Nov 25;11:731905. doi: 10.3389/fonc.2021.731905. eCollection 2021.